Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724436 | SCV000700767 | uncertain significance | not provided | 2017-03-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724436 | SCV000729311 | likely benign | not provided | 2021-04-21 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000785080 | SCV000923635 | uncertain significance | Developmental and epileptic encephalopathy, 36 | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000785080 | SCV000950892 | likely benign | Developmental and epileptic encephalopathy, 36 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002530951 | SCV003701516 | likely benign | Inborn genetic diseases | 2021-04-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000724436 | SCV004167461 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | ALG13: BS2 |
Genome Diagnostics Laboratory, |
RCV000724436 | SCV001927780 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000724436 | SCV001974352 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003915690 | SCV004736062 | likely benign | ALG13-related disorder | 2019-02-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |